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Abstract
Two mathematical models described by simple ordinary di↵erential equations
are developed to investigate the Hong Kong influenza epidemic during 2017 -
2018 winter, based on overall epidemic dynamics and di↵erent influenza sub-
types. The first model, describing the overall epidemic dynamics, provides the
starting data for the second model which di↵erent influenza subtypes, and whose
dynamics is further investigated. Weekly data from December 2017 to May 2018
are obtained from the data base of the Centre of Health Protection in Hong
Kong, and used to parametrise the models. With the help of these models,
we investigate the impact of di↵erent vaccination strategies and determine the
corresponding critical vaccination coverage for di↵erent vaccine e cacies.
The results suggest that at least 72% of Hong Kong population should have
been vaccinated during 2017 - 2018 winter to prevent the seasonal epidemic
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by herd immunity (while data showed that only a maximum of 11.6% of the
population were vaccinated). Our results also show that the critical vaccination
coverage decreases with increasing vaccine e cacy, and the increase in one in-
fluenza subtype vaccine e cacy may lead to an increase in infections caused by
a di↵erent subtype.
Keywords: Influenza, SVIR model, Vaccination coverage, Vaccine e cacy
1. Introduction
Approximately 10-20% of the world’s population is infected with influenza
viruses every year and it is expected that up to 15% of European population is
infected by influenza in any winter season [1, 2]. The World Health Organisation
(WHO) stated that annual epidemics are estimated to cause 3 to 5 million cases
of severe illness and about 290 000 to 650 000 deaths worldwide [3].
Hong Kong usually experiences one or two peak seasons of influenza in one
epidemic year [4]. Researches have shown that influenza season peaked at low or
high temperature with high relative humidity [5]. Being a city in the subtrop-
ical region of southern China, Hong Kong experiences high humidity (> 70%)
throughout the year, along with low temperature in the winter (⇠ 15 C) and
high temperature in the summer (⇠ 30 C) [6], which account for the two in-
fluenza peak seasons every year. The influenza season in Hong Kong usually last
for two months for each period - one from January to March (winter season),
the other from July to August (summer season). The high population density in
Hong Kong also makes influenza easier to spread among humans, as they have
a higher chance of contact with the infected individuals.
Several studies have focused on di↵erent factors a↵ecting the influenza epi-
demics in Hong Kong, such as the weather [5], the change in seasonal pattern
after 2009 pandemic [7], and the anti-phase synchronisation between type A
viruses [8]. These studies are useful in preparing and predicting future epi-
demics in Hong Kong. Nonetheless, to prevent epidemics one needs to focus on
vaccination and its e↵ect can be investigated by means of mathematical models
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and simulations [9].
Mathematical models are useful in investigating the dynamics and control of
infectious diseases. Previous studies have examined various models for influenza
epidemics in di↵erent contexts, such as the epidemics of one influenza strain [10],
competitive interference between multiple influenza viral strains [11], and the
cross-protective immunity between di↵erent strains [12]. Mathematical models
also provide useful and inexpensive tools to test hypotheses on the optimal way
to control the spread of an infection, notably through vaccination [13]. Several
studies have used mathematical models to evaluate various control strategies
and to design the best strategy [13, 14, 15]. However, because of the complex-
ity of epidemics dynamics, it is still an open question to determine the best
vaccine strategy for alleviating the influenza epidemics. For instance, influenza
epidemics depend on multiple influenza subtypes and vaccination against only
one subtype could lead to a negative impact on di↵erent subtypes [16].
This paper proposes two deterministic SVIR models based on the infection
data in Hong Kong during the 2017 - 2018 winter, which are then used to
investigate the e↵ects of vaccine strategies based on vaccination coverage and
vaccine e cacy against di↵erent influenza subtypes. We begin by introducing
the first SVIR model (model 1) describing the overall influenza epidemic, which
provides the starting data for the second SVIR model (model 2) describing
the epidemic in the context of three major influenza subtypes (AH1, AH3 and
B) in Hong Kong. We parametrise the models based on the available data
for the 2017 - 2018 influenza in Hong Kong. We then present the results of
numerical simulations for these two models as we vary di↵erent parameters
values associated with di↵erent vaccine strategies. Our work is di↵erent from
the previous mathematical approaches in the literature (e.g., a SIR model with
one influenza subtype [13], a SVIR model with vaccination against one influenza
subtypes [15], a seasonal SEIAR model [14], and two-strains SVIR model [16])
by its use of data on the 2017 - 2018 influenza in Hong Kong and the proposal of
a new mathematical model with the composite vaccine based on three influenza
subtypes.
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2. Mathematical Models
2.1. Epidemic Data
We obtained the data from the data base of the Centre of Health Protection
in Hong Kong (CHP), which included influenza related statistics of Hong Kong
[17]. Two major data sets were used in the paper:
1. Positive percentage of seasonal influenza viruses among respiratory speci-
mens received in Laboratory (D1);
2. Influenza-associated hospital admission rates in public hospitals (D2).
Figure 1 shows both data sets from 1st October 2017 to 5th May 2018. Since
type C viral infections remained at a steady, significantly low level, and strain C
was never a dominating virus in any peak season, throughout this study (and in
particular for model 2) we considered for simplicity only the type A(H1), A(H3)
and B viruses.
Figure 1: Surveillance data obtained from CHP from 1st October 2017 to 5th May 2018. (Top)
Positive percentage of seasonal influenza viruses among respiratory specimens received in
Laboratory (D1). (Bottom) Influenza-associated hospital admission rates in public hospitals
(D2).
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The influenza season of 2017 - 2018 winter was identified by CHP on the basis
of influenza surveillance data. Respiratory specimens were received and tested
each week by CHP to detect and distinguish the pathogens from the specimens.
Once the positive detection of seasonal influenza viruses exceeded the baseline
threshold of 10.7% among the specimens [18, 19], Hong Kong was considered
to have entered the influenza season, while the decline on the percentage back
to the baseline level marked the end of the influenza season. CHP announced
that the influenza season in 2017-18 winter was detected between 7th January
and 31st March 2018 [18, 19]. This period is denoted in the paper as the “peak
season”, to separate it from the annual influenza activity. In order to improve
fitting accuracy, more weekly data were needed for fitting. Therefore, the period
from 10th December 2017 to 5th May 2018 was chosen to be investigated as both
data sets (D1 and D2) started to increase significantly from 10th December 2017
and were maintained at a low level after the peak season. We refer to this period
as the “Study Period”.
Several assumptions were made for the models introduced in this study:
1. Hong Kong has an estimated population of 7.4 million [20].
2. There was no net growth rate of the population over the study period.
3. 15% of Hong Kong population was infected by influenza over the peak
season.
4. Individuals only got vaccinated through the government subsiding schemes
and vaccine did not wane during the period.
5. Incubation period was ignored.
6. All individuals were capable of infections at the start of the study period
(including the vaccinated ones since the vaccine e cacy was lower than
100%).
7. Once recovered from infection, individuals had gained immunity against
influenza and they did not get infected by influenza again during the rest
of the season.
8. No cross-infection occurred, i.e. individuals did not get infected by two or
more influenza subtypes at the same time or one after another.
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Given the worldwide infected statistics and situation in Hong Kong (as dis-
cussed in Section 1), throughout the study we assumed that 15% of the Hong
Kong population was infected during the peak season. Also, as it was generally
expensive to get vaccinated and limited vaccines were available in Hong Kong,
we assumed that individuals only got vaccinated via the government subsiding
schemes, i.e. the number of vaccinated individuals were recorded and announced
by o cial organisations. More information about the government vaccination
programme can be obtained via the government website [21].
2.2. Vaccination
Two vaccines composed of A(H1), A(H3) and B viruses were recommended
in Hong Kong during the 2017 - 2018 winter. The compositions of the vaccines
can be found in Appendix A. CHP had established several vaccination schemes
to provide free or subsidised seasonal influenza vaccinations to several groups
of Hong Kong residents, including pregnant women, elderly, infants and chil-
dren, whom are considered to have a higher risk of infection due to their low
immunity [22]. We obtained the number of vaccinations from the CHP website
and newsletters; these numbers are represented by the red squares in Figure 2.
Note here that the vaccination numbers followed an inverse exponential decay
pattern (i.e., the solution of the following equation),
dV
dt
= r
⇣
1  V
A
⌘
= f(V ), (1)
where r and A denote the growth rate and the maximum of vaccinated popu-
lation respectively. These two parameters are estimated using the least squares
method (which approximates the parameters by minimizing the square errors
between the numerical curve and the data). In general, a vaccine becomes e↵ec-
tive two weeks after the injection [23]. If the “e↵ectively vaccinated population”
is defined as those individuals who obtained e↵ective vaccine protection, then
we can use equation (1) with two weeks delay to describe the number of ef-
fectively vaccinated population. Both curves are shown in Figure 2, the blue
curve describing the solution of equation (1) fitted to the data, and the orange
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curve describing the solution of equation (1) shifted by two weeks (i.e. the ef-
fective vaccinated population). Note that, throughout this study we focus only
on the e↵ectively vaccinated population. (Those who have not acquired vaccine
protection are still in the susceptible class).
Figure 2: Vaccinated population in Hong Kong over the 2017-18 winter. The red squares and
the blue curve represent the data from CHP and its fitted curve respectively. The orange
curve is actually the blue curve with a 2-weeks delay to represent the e↵ectively vaccinated
population. The week beginning 10th December 2017 was the start of the study period and of
the peak season, and hence V0 was chosen to be the initial value of both e↵ectively vaccinated
and vaccinated compartments over this period.
Using equation (1) and the data in Figure 2, we estimated the parameter
values to r = 0.0155 and A = 0.1155 (which indicated that a maximum of
⇠ 11.6% population had been vaccinated by the end of the season; refer to the
population size in Figure 2 on the week beginning 29 April). V0 ⇡ 0.0565 is
the initial value of both vaccinated and e↵ectively vaccinated compartments in
the models. We will discuss these compartments in Sections 2.3.1 and 2.4.1.
This V0 value was chosen by focusing on the orange curve (i.e., the e↵ective
vaccinated population in Figure 2), and assuming that the initial time (t=0) for
simulations was the week beginning 10th December 2017.
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The vaccine e cacy (VE) of influenza B viruses was obtained from CHP [24].
Because of insu cient data regarding VE for influenza A viruses in Hong Kong,
such data was obtained from the Center for Disease Control and Prevention
of the United States [25]. The overall VE was calculated using the subtypes
VE and the ratio of subtypes infections data to overall infections data (D1 of
Figure 1) from 5th November 2017 to 5th May 2018:
VEOverall =
iX Pj D1iPj D1total ·VEi, i = subtypes, j = no. of weeks. (2)
Note that the influenza C virus was not included in the trivalent vaccine (see
also Appendix A), and the e↵ect of this virus on the VE calculation is negligible.
Subtype Vaccine E cacy References
A(H1) 67% [25]
A(H3) 25% [25]
B 40% [24]
Overall 45% Calculated
Table 1: The e cacy of influenza vaccine against di↵erent viral subtypes.
In the following subsection, we start with a simple model in which we aver-
age the e↵ect of all infection strains, and use this model to obtain an estimate
of the average transmission and recovery rates. These rates will be used to ap-
proximate the corresponding rates for the more complex model 2 where di↵erent
infection strains will be distinguished.
2.3. SVIR Model 1
2.3.1. Model Description
A SVIR model is proposed for the overall influenza epidemic in Hong Kong:
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dS
dt
=   IS   r 1  Ve
A
 
, (3a)
dV
dt
= r
 
1  Ve
A
   kIV, with k =  (1  w), (3b)
dVe
dt
= r
 
1  Ve
A
 
, (3c)
dI
dt
=  IS + kIV    I, (3d)
dR
dt
=  I. (3e)
S : Susceptible V : Vaccinated I : Infected
R : Recovered Ve : E↵ectively Vaccinated
Table 2: Description of compartments of model 1.
Figure 3: Transfer diagram for the SVIR model 1 given by equations (3). Here, f(Ve) =
r(1  VeA ).
We divide the Hong Kong population into 4 compartments: Susceptible
(S), Vaccinated (V), Infected (I), and Recovered (R). Since population in the
vaccinated compartment V decreases because of infections, and thus cannot
represent the true e↵ectively vaccinated population (Figure 2), a separate sub-
compartment Ve is introduced to show the e↵ectively vaccinated population
(although this is part of the compartment V). It is noted that both V and Ve
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share the same initial value as both compartments are the same at the beginning.
The model is explained graphically in Figure 3 and can be described as follows.
Susceptible individuals are infected at a rate  SI and vaccinated at a rate f(Ve)
(see equation (1)). Since the vaccine is not perfect (i.e., VE< 100%), vaccinated
individuals are infected at a rate kV I, where k depends on the vaccine e cacy
w and on the transmission rate  :
k =  (1  w). (4)
This equation has been adopted to show a “leaky” vaccine that o↵ers partial
protection to every vaccinated individual [26, 27, 28]. After being recovered
from influenza at a rate  I, individuals are assumed to gain immunity and will
not be infected again. The drawbacks of this assumption will be discussed in
the “Discussion and Conclusion” section.
To simplify the calculations, since we assumed no net population growth rate
and the total population of Hong Kong was 7.4 million during the study period,
we rescaled the model such that the sum of the 4 compartments becomes equal
to 1, i.e.,
S + V + I +R = 7.4 million
) S¯ + V¯ + I¯ + R¯ = 1 (5)
with the bars being removed for simplicity.
2.3.2. Parameters Estimation
The weekly hospital admission data of di↵erent influenza subtypes (DATA)
was obtained using the data sets D1 and D2 shown in Figure 1:
DATAsubtype = D2 · D1subtype
D1total
, (6)
and the result was plotted in Figure 4. The vertical blue dotted lines indicate
the peak season (as determined in [18, 19]) and the vertical red dotted lines
mark the two events related to the vaccination:
(1) Start of the vaccination schemes (week beginning 22nd October 2017);
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(2) Time when the first vaccination started to be e↵ective (week beginning 5th
November 2017).
Figure 4: Weekly hospital admission data of di↵erent influenza subtypes (DATA) from 1st
October 2017 to 5th May 2018. “(a)” indicates the start of vaccination schemes and “(b)”
indicates the week when first vaccination started to be e↵ective. The peak season is bounded
by the purple dotted lines.
As it is impossible to obtain the actual number of infections in Hong Kong,
we need to estimate the actual number of infections using the available data.
We assume that the actual number of weekly infections is directly proportional
to the weekly hospital admissions due to influenza (DATA) (see equation (6)
and Figure 4), with the proportionality ratio ↵. Since we also assumed that
15% of Hong Kong population was infected by influenza over the peak season
(see the assumption in Section 2.1), we transform DATA within the peak season
into a cumulative distribution (C) and use the following equation to estimate
↵:
↵ =
HK population ·% of infection over the season
Cend of season
) (7)
↵ =
7.4 million · 0.15
0.0012
⇡ 127.
To estimate the actual weekly number of infections of di↵erent influenza sub-
types (DATA2), we then multiply the weekly hospital admission data (DATA)
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by the proportionality ratio ↵, as follows:
DATA2 (weekly) = ↵ ·DATA (weekly). (8)
DATA2 is plotted in Figure 5. In Figure 6 we plot the infected compartment
of model 1 against DATA2. The approach taken in this figure (i.e. fit the in-
fected compartment to the observed data) is di↵erent from the classical approach
(where one integrates  I and then matches it to weekly data [29, 30]). The red
squares in the figure show the total infection data from DATA2 and its cumula-
tive distribution over the study period. The model is fitted to the data by least
squares method to determine the parameters. The initial value I(0) = 0.0012 is
obtained from DATA2, R(0) = 0 by assumption, V (0), Ve(0) ⇡ 0.0565 (with V0
from Figure 2), and S(0) = 0.9424 is calculated by equation (5).
Figure 5: Weekly infection data of di↵erent influenza subtypes (DATA2) over the study
period. Influenza peak season is bounded by the dotted lines.
From the fitting in Figure 6, we obtain the average transmission rate and
the recovery rate:   ⇡ 2.7516 and   ⇡ 2.1272. We then use the following
relationship between the recovery rate   and the recovery period T,
T (day) =
1
  (week 1)
· 7, (where 7 days = 1 week) (9)
to approximate the recovery period to T ⇡ 3.29 days. Note that this period
is slightly shorter than the recovery period for di↵erent past seasonal influenza
12
Figure 6: Infected compartment of model 1 and its cumulative distribution over study period.
Red squares indicate the weekly data and the blue curves are the fitted numerical solution of
model 1.
epidemics (for example, [31] approximated the recovery period to 4.1 days, while
[32] used a recovery period of 3.8 days). The parameters are listed in Table 3
and the dynamics of the SVIR model is plotted in Figure 7. The details of the
linear stability analysis of model 1 are discussed in Appendix B. We will use
the approximated values of   and   in the next section, where we will focus on
infections with di↵erent influenza subtypes.
Figure 7: Dynamics of SVIR model 1 over the study period.
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Symbol Description Value References
↵ Infected ratio 127 Calculated
S(0) Initial value of compartment S 0.9424 Calculated
V(0) Initial value of compartment V 0.0565 Figure 2
Ve(0) Initial value of compartment Ve 0.0565 Figure 2
I(0) Initial value of compartment I 0.0012 DATA2
R(0) Initial value of compartment R 0 Assumed
r Growth rate of e↵ectively vaccinated popula-
tion
0.0155 Fitted
A Maximum of e↵ectively vaccinated population 0.1155 Fitted
  Transmission rate of susceptible individuals
(1/week)
2.7516 Fitted
  Recovery rate (1/week) 2.1272 Fitted
w Overall vaccine e cacy 0.45 Table 1
k Infection rate (1/week) of vaccinated individu-
als, calculated using the formula k =  (1 w)
1.5134 Calculated
T Recovery period (days) 3.29 Calculated
R0 Basic reproductive ratio 1.2935 Calculated
R0x E↵ective reproductive ratio 1.2607 Calculated
Table 3: Parameters used in model 1, with their descriptions and approximated values.
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2.4. SVIR Model 2
2.4.1. Model Description
Next we propose another SVIR model (relatively similar to model 1) which
distinguishes between the infection generated by di↵erent influenza subtypes.
For indices i = A(H1), A(H3), B, corresponding to the influenza A(H1),A(H3)
and B viruses, we have
dS
dt
=  
3X
i=1
 iIiS   r(1  Ve
A
) (10a)
dV
dt
= r(1  Ve
A
) 
3X
i=1
kiIiV, ki =  i · (1  wi) (10b)
dIi
dt
=  iIiS + kiIiV    iIi (10c)
dR
dt
=
3X
i=1
 iIi (10d)
dVe
dt
= r(1  Ve
A
) (10e)
S : Susceptible V : Vaccinated IA(H1) : Type A(H1) Infected
IA(H3) : Type A(H3) Infected IB : Type B Infected R : Recovered
Ve : E↵ectively vaccinated
Table 4: Description of compartments of model 2.
Similar to model 1, we divide the Hong Kong population into 6 compart-
ments: Susceptible (S), Vaccinated (V), type A(H1) Infected (IA(H1)), type
A(H3) Infected (IA(H3)), type B Infected (IB), and Recovered (R). As in model
1, in addition to the compartment V, we consider the sub-compartment Ve
describing the e↵ectively vaccinated population. The model is explained graph-
ically in Figure 8 and can be described as follows. Susceptible individuals are
infected by influenza subtypes i at a rate  iSIi and vaccinated at a rate f(Ve)
(see equation (1)). Since the vaccine is not fully protective on each subtype
15
Figure 8: Transfer diagram of SVIR model 2. f(Ve) = r(1  VeA )
(wi < 100%), vaccinated individuals are infected at a rate kiV Ii where ki de-
pends on the vaccine e cacy wi and on the transmission rate  i:
ki =  i(1  wi), where i = A(H1), A(H3), B. (11)
This equation has been adopted to show a ”leaky” vaccine that o↵ers partial
protection to every vaccinated individual [26, 27, 28]. After being recovered from
influenza at a rate  iIi, individuals are moved to the recovered compartment R.
For simplicity, we assume no cross-infections between viruses, and individuals
who were once infected obtain immunity and will not be infected again by any
other influenza viruses. The drawbacks of this assumption will be discussed in
the “Discussion and Conclusion” section.
As we assumed no net population growth rate and the total population of
Hong Kong was 7.4 million during the study period, the model is re-scaled such
that the sum of the 6 compartments equals to 1, i.e.,
S + V + IA(H1) + IA(H3) + IB +R = 7.4 million
) S¯ + V¯ + ¯IA(H1) + ¯IA(H3) + I¯B + R¯ = 1 (12)
with the bars being removed for simplicity.
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2.4.2. Parameters Estimation
DATA2 are used for the fitting in model 2 (Figure 5). The initial values of
infected compartments, IA(H1), IA(H3), IB are obtained from DATA2 (please
see Table 6). Similar to model 1, we choose R(0) = 0, V (0), Ve(0) ⇡ 0.0565 (V0
from Figure 2), while S(0) = 0.9425 is calculated by equation (12).
Since more parameters are involved in this model, we combine the bootstrap
method with the least squares method to estimate the parameters and show the
fitting accuracy. The bootstrap method is a numerical techniques for statistical
inference, which is used to show the accuracy of the estimators for the unknown
parameters [9]. In order to use this method, we re-sample DATA2 to be Poisson
distributed at a fixed time, with mean equal to the original data. Each set of
generated samples is used to simulate a similar influenza season and least squares
method is used to determine the parameters in each simulation; this procedure
is repeated 2000 times. Figure 9 and Table 5 show the distributions and results
of bootstrapping estimation of the parameters. As A(H3) viral infections were
insignificant compared to other 2 subtypes, we assumed the recovery rate of
A(H3) viruses to be the average recovery rate estimated in Table 3 (to facilitate
the MATLAB estimator to converge to a set of parameter values).
Symbol Fitted value Mean S.D. 95% C.I
 A(H1) 1.9528 1.9400 0.1160 [1.6070 2.0911]
 A(H3) 2.5911 2.5911 0.0068 [2.5807 2.6018]
 B 3.0911 3.0953 0.0229 [3.0698 3.1702]
 A(H1) 1.3581 1.3471 0.0963 [1.0693 1.4699]
 B 2.4138 2.4179 0.0209 [2.3983 2.4928]
Table 5: Bootstrapping results.
The infected compartments of the model are shown in Figure 10. The fitted
value of each parameter in Table 5 is taken from the mean value of the middle
10% of the histograms in Figure 9. The recovery period T can then be calculated
using equation (9). The parameters are listed in Table 6 and 7, and the dynamics
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Figure 9: Histogram results of the bootstrap method.
of the SVIR model is plotted in Figure 11a. In order to show the dynamics of
the infection compartments clearly, their dynamics are plotted in Figure 11b
with an appropriate scale.
The infected compartments of model 2 (10) are shown in Figure 10. The
fitted value of each parameter in Table 5 is taken from the mean value of the
middle 10% of the histograms in Figure 9. The recovery period T can then be
calculated using equation (9). The parameters are listed in Table 6 and 7, and
the dynamics of the SVIR model is plotted in Figure 11a. In order to show
the dynamics of the infection compartments more clearly, their dynamics are
plotted in Figure 11b on an appropriate vertical scale.
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Figure 10: Infected compartments of model 2 and their cumulative distributions. (Upper
row) Time-evolution of the infected compartments of model 2, and (Lower row) their cumu-
lative distributions. Red squares indicate the weekly data and the blue curves are the fitted
numerical solution of model 2.
As observed in Figure 10, the estimation of influenza A(H1) and B infections
are satisfactory, but the fitted curve for influenza A(H3) viruses is below the
actual data towards the end of the season. Since the infected compartment of
the SVIR model (10) will approach a zero steady state as time goes by (as it will
be discussed later in this section), the di↵erence between the zero steady states
and the real data will be significant if the data remained at a low nonzero level
throughout the period of interest. As the A(H3) viral infections remained at a
significant low level that was on a comparable scale to the number of influenza
infections in the non-peak season (see Figure 1), this di↵erence is significant,
and cannot be eliminated. However, since the B viral infections occurred in
greater numbers (see Figure 1), this di↵erence between simulated curve and
actual data is negligible.
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(a) All compartments
(b) Infected compartments
Figure 11: Dynamics of SVIR model 2 over study period.
2.4.3. Steady States and Their Stability
The details of the linear stability analysis for model 2 are discussed in Ap-
pendix C. From this analysis, R0 and R0x of each virus subtype are defined as
follows (see equation (24) and (25) in Appendix C):
R0i =
 i
 i
, i = A(H1), A(H3), B, (13)
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Symbol Description Value References
↵ Infected ratio 127 Calculated
S(0) Initial value of compartment S 0.9425 Calculated
V(0) Initial value of compartment V 0.0565 Figure 2
Ve(0) Initial value of compartment Ve 0.0565 Figure 2
IA(H1)(0) Initial value of compartment IA(H1) 1.3062e
 4 DATA2
IA(H3)(0) Initial value of compartment IA(H3) 1.3062e
 4 DATA2
IB(0) Initial value of compartment IB(0) 7.5470e 4 DATA2
R(0) Initial value of compartment R 0 Assumed
r Growth rate of e↵ectively vaccinated popula-
tion
0.0155 Fitted
A Maximum of e↵ectively vaccinated population 0.1155 Fitted
 A(H1) Transmission rate of A(H1) viruses of suscep-
tible individuals (1/week)
1.9528 Fitted
 A(H3) Transmission rate of A(H3) viruses of suscep-
tible individuals (1/week)
2.5911 Fitted
 B Transmission rate of B viruses of susceptible
individuals (1/week)
3.0911 Fitted
 A(H1) Recovery rate of A(H1) viruses (1/week) 1.3581 Fitted
 A(H3) Recovery rate of A(H3) viruses (1/week) 2.1272 Table 3
 B Recovery rate of B viruses (1/week) 2.4138 Fitted
wA(H1) Vaccine e cacy of A(H1) viruses 0.67 Table 1
wA(H3) Vaccine e cacy of A(H3) viruses 0.25 Table 1
wB Vaccine e cacy of B viruses 0.4 Table 1
TA(H1) Recovery period of A(H1) viruses (days) 5.15 Calculated
TA(H3) Recovery period of A(H3) viruses (days) 3.29 Calculated
TB Recovery period of B viruses (days) 2.90 Calculated
Table 6: Parameters used in model 2, with their descriptions and approximated values.
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Symbol Description Value References
kA(H1) Transmission rate of A(H1) viruses of vacci-
nated individuals (1/week)
0.6444 Calculated
kA(H3) Transmission rate of A(H3) viruses of vacci-
nated individuals (1/week)
1.9433 Calculated
kB Transmission rate of B viruses of vaccinated
individuals (1/week)
1.8547 Calculated
R0A(H1) Basic reproductive ratio of A(H1) viruses 1.4378 Calculated
R0A(H3) Basic reproductive ratio of A(H3) viruses 1.2181 Calculated
R0B Basic reproductive ratio of B viruses 1.2806 Calculated
R0xA(H1) E↵ective reproductive ratio of A(H1) viruses 1.3834 Calculated
R0xA(H3) E↵ective reproductive ratio of A(H3) viruses 1.2009 Calculated
R0xB E↵ective reproductive ratio of B viruses 1.2517 Calculated
Table 7: Parameters used in model 2, with their descriptions and approximated values (Con-
tinue).
R0xi =
 i
 i
(1  wiV0), i = A(H1), A(H3), B, V0 = V (0). (14)
Using the parameter values from Table 6, we can obtain both reproductive ratios
(R0i and R0xi) for each virus subtype (see their values in Table 7). Since R0x of
all virus subtypes are greater than one over the whole study period, infections
from all subtypes continued to spread.
The steady states of the model 2 are
(S, V, Ve, IA(H1), IA(H3), IB , R) = (1  V ⇤  R⇤, V ⇤, A, 0, 0, 0, R⇤),
where 0  V ⇤, R⇤, V ⇤ + R⇤  1, V ⇤  A. We consider R(0) = R⇤ and
V (0) = V ⇤ to observe the stability of the steady states at the beginning of
the influenza season. By simple calculation we can find the eigenvalues of the
Jacobian matrix associated with the system (10) (see also equation (26) in
Appendix C):
 i =  i
 
1  wiV (0) R(0)
    i, where i = A(H1), A(H3), B. (15)
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Hence if the inequality
 i
 
1  wiV (0) R(0)
    i > 0
is satisfied for any subtype i, the steady states are unstable. We then consider
  to be the largest  i (i.e.,   = max i); then   < 0 indicates that the steady
state is stable (since max i < 0)  i < 0, 8 i).
Figure 12: The dynamics of the determining eigenvalues  j in the (V ⇤, R⇤)=(V (0), R(0))
space, for di↵erent vaccine e cacies w = wA(H1) = wA(H3) = wB and influenza subtypes
j. The baseline vector w0 = (wA(H1), wA(H3), wB) = (0.62, 0.25, 0.4) is obtained from Ta-
ble 6. In each sub-figure the solid, dashed-dotted and dashed lines represent  j = 0, where
j = A(H1), A(H3) and B respectively (see equation (26) in Appendix C). The shaded areas
represent the values of V (0) and R(0) where max( j) > 0.
Figure 12 shows the changes in the stability of the steady state (correspond-
ing to the changes in the sign of  ) for di↵erent vaccine e cacies w = wA(H1) =
wA(H3) = wB . If we now focus on the case R(0) = V (0) = 0 at the beginning
of the season, we observe that this disease-free equilibrium is always unstable,
i.e., a single infection case will cause the spread of the influenza. As the vaccine
e cacies w increase (w = 0.1 ! 0.5 ! 0.8), the level of the initial vaccinated
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population V (0) that can ensure stable steady states does decrease (see how the
unshaded region in Figure 12 moves towards left). We also observe that when
w = 0.1 and R(0) ⇡ 0, the disease-free equilibrium is unstable even if the whole
Hong Kong population are vaccinated (V (0) = 1).
3. Numerical Simulations
In this section, we investigate the e↵ects of di↵erent vaccination strategies
applied to model 2 (given by equations (10)), where we change the initial vac-
cinated population V(0) and the vaccine e cacy wi of each influenza subtype.
For each strategy, all parameters are assumed to be the same as in Table 6 and
Table 7 except for the parameter that we are changing.
3.1. Initial Vaccinated Population
We assume that the initial vaccinated population is constant and no further
vaccination occurs, i.e., A = V (0), 0 < V (0) < 1, r = 0. Then equation (10b)
becomes
dV
dt
=  
3X
i=1
kiIiV. (16)
We observe in Figure 13 that by increasing V (0), the influenza epidemic becomes
smaller and smaller. We also observe that, for di↵erent influenza subtypes,
di↵erent V(0) are required to clear out the infections spread from the beginning.
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Figure 13: The dynamics of SVIR model 2, for di↵erent initial vaccination population. A =
V (0) = Ve(0). The baseline A = 0.0565 is obtained from V (0) in Table 6.
3.2. No Vaccination
In Figure 14 we consider the case when no vaccine is available in Hong Kong
and thus no one is vaccinated during the influenza season. Without vaccine
protection (i.e., V (t) = 0, 8t   0), it is obvious that the total number of
infections will be higher. Because of the small A(H3) infected population and
the low VE of A(H3) viruses, the vaccination against A(H3) has an insignificant
e↵ect.
To see more clearly why these results hold, let us return to system (10) where
we add the susceptible and vaccinated compartments:
d(S + V )
dT
=  
3X
i=1
 iIi
⇣
S + (1  wi)V
⌘
) d(S + V )
dT
=  
3X
i=1
 iIi(S + V ), if wi = 0 8i.
Relabelling S + V = S˜, we have
S˜ =  
3X
i=1
 iIiS˜. (17)
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Figure 14: The dynamics of SVIR model 2 without any vaccination. Bottom right panel shows
the summation of susceptible and vaccinated compartments.
Thus, if the vaccine is not e↵ective at all (wi = 0, 8i), it will result in the same
situation as when no one has been vaccinated.
3.3. Vaccine E cacy
In general, the influenza vaccines can have low e cacies (i.e., wi < 1) [33].
However, vaccine e cacy could be increased by increasing the vaccine immuno-
genicity or the breadth of the immune response, which can be done, for example,
by incorporating adjuvants (that stimulate the antiviral immune response, and
thus can increase vaccine e↵ectiveness against all strains), or by injecting higher
amounts of virus antigens (and thus increasing vaccine e↵ectiveness against the
particular virus strain injected at higher levels) [34, 35].
Mathematically, we can investigate the possible increase in vaccine e cacy
(VE) by considering the following two cases/methods:
1. Change one VE (i.e. wi for i = A(H1), A(H3) or B) while keeping other
two VE unchanged (see Figure 15).
2. Change all VE together to one fixed value w = wA(H1) = wA(H3) = wB
(see Figure 16).
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Note that changing the vaccine e cacies wi leads to changes in the infection
rates ki for the vaccinated individuals; see equation (11).
Figure 15: The dynamics of SVIR model 2, when the vaccine e cacy of each influenza
subtype is being changed separately. In the legend, we denoted by w the e cacy vector
w = (wA(H1), wA(H3), wB). The baseline vector w0 = (0.67, 0.25, 0.4) contains the baseline
e cacy parameters identified for model 2 (see Table 6). (Top row) wA(H1) is being changed.
(Middle row) wA(H3) is being changed. (Bottom row) wB is being changed.
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Figure 16: The dynamics of SVIR model 2, when the vaccine e cacies for the influenza
subtypes are being changed together to one fixed scalar value w = wA(H1) = wA(H3) = wB .
The baseline (i.e., original) vector w0 = (0.67, 0.25, 0.4) is obtained from Table 6.
For method 1 (see Figure 15), we observe that when wi for subtype i is higher
than its baseline value in the vector (wA(H1), wA(H3), wB) = (0.67, 0.25, 0.4), the
results always show smaller epidemics of that particular subtype. However, the
increase of any VE will lead to an increase in the number of infections for the
other two subtypes. Since the infections with one subtype decreased, it lead to
more susceptibles that can be infected by the other two virus subtypes. Also,
since the decrease of B infections released many more susceptibles (as B strain
was the dominant virus), the number of infections with other two subtypes
increased significantly.
A similar trend can be observed for method 2 (see Figure 16). Although the
number of infections with A(H3) and B viruses decreased with the increase in the
VEs (see the middle and right panels in Figure 16), a more severe epidemic was
caused by the A(H1) virus (see the left panel). This could be the result of the
higher reproductive ratio of A(H1) (see Table 7, where R0xA(H1) is the highest
among the three subtypes), and that the stop of the spread of B infections
(which is the dominant virus in that season) will lead to more susceptible for
the spread of A(H1) infections. We will return to this discussion in Section 3.5.
In addition, we observe that the perfect vaccine e cacy cannot stop the
spread of influenza infections (see the yellow curves for w = 1 in Figure 16). We
hypothesise that the current level of vaccination coverage in Hong Kong is not
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enough to stop the spread of the infection. We will return to this discussion in
Section 3.6.
3.4. Partially Perfect Vaccine
We observe from Section 3.3 that A(H1) viral infections will become severe
if a perfect vaccine is introduced. In this Section we carry out simulations to
investigate if there are any possible VE combinations that will result in a smaller
epidemic.
Figure 17: The dynamics of SVIR model 2, when we vary the vaccine e cacy against one
subtype and assume 100% e cacies against the other two subtypes. The e cacy vector is
w = (wA(H1), wA(H3), wB). (Top row) The e↵ect of varying wA(H1). (Middle row) The e↵ect
of varying wA(H3). (Bottom row) The e↵ect of varying wB .
First, we define a “partially perfect vaccine” to be a vaccine with 100% VE
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on any two influenza subtypes and less than 100% VE on the third subtype.
Second, we assume that the vaccination coverage is as described in Figure 2.
Moreover, we assume 100% VE on any 2 influenza subtypes, with the remaining
subtype VE varying from 40% to 100%. The simulation results are plotted in
Figure 17. We can easily observe that an increase in one VE will always lead
to an increase in the number of A(H1) infections. A possible explanation for
this increase is discussed in more detail in Section 3.5. However, despite the
increase in the A(H1) infections, we note that the total number of infections is
decreasing with increased vaccine e cacy wi, and the perfect vaccine (obtained
for wi = 1, 8i) will result in the smallest epidemic; see the fourth column in
Figure 17.
3.5. Parameter sensitivity test on changes in wi
Sensitivity of R0xi
A puzzling result in Sections 3.3 and 3.4 was that when VE was high (e.g.,
100%), the number of A(H1) infections still increased. To obtain a better under-
standing of the mechanisms behind this increase, here we focus on the e↵ective
reproductive ratio for each influenza subtype R0xi (as given by equation (14)):
R0xi =
 i
 i
 
1  wiV0
 
, i = A(H1), A(H3), B.
In Figure 18 we show the changes in R0xi as functions of wi, where the rest of
the parameter values are fixed as in Table 6.
Since the vaccinated population increases as time passes (see Figure 2), by
mid February (⇡ week 10) R0xA(H1) should still be the highest among the
e↵ective reproductive ratios for the three influenza subtypes (where R0xi are
calculated based not on the original V0 but on the V on⇡ week 10). Moreover, as
the e cacies increase towards wi = 1, R0xA(H3) and R0xB are decaying towards
the value 1.1 while R0xA(H1) is still well above the value 1.3 (see Figure 18),
and thus we still expect a fast increase in the A(H1) cases. In addition, since
the number of B infections (the highest among the three subtypes) has been
reduced, it leaves more susceptible for the A(H1) infections. When these two
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Figure 18: Plot of e↵ective reproductive ratio for each influenza subtype i (R0xi) against
vaccine e cacy (wi). R0x is calculated using equation (14). The parameters used in the
equation are obtained from Table 6.
factors co-exist (i.e., higher R0x(AH1) and more susceptibles), the number of
A(H1) infections increases to values larger than the original/baseline ones (as
observed in Figures 15-17). This explanation can account also for the small
increase in the A(H3) infections shown in Figure 17 bottom row as we increase
wB = 0.4! 0.7! 1 (since R0xA(H3) is still relatively high, and more susceptible
are in the environment due to the increase in the e cacy of B vaccine).
Sensitivity of attack rate
Next, we perform a Partial Rank Correlation Coe cient (PRCC) sensi-
tivity analysis [36] with the help of R software (function pcc of the package
sensitivity). To this end, we simulate the impact of three vaccine e cacies
(wA(H1), wA(H3), wB) on the attack rate (cumulated proportion) of influenza
virus strains A(H1), A(H3) and B (see Figure 19). For the sampling, we sample
randomly 1000 times each of the parameters wA(H1), wA(H3), wB from the range
[0,1]. Then, we calculate the PRCC of cumulative cases of influenza virus strains
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A(H1), A(H3) and B against the e cacy parameters wA(H1), wA(H3) and wB .
Note that the PRCC values that are closer to +1 or -1 indicate that the sam-
pling parameter has a greater influence on the outcome measure [36]. Moreover,
a negative sign indicates that the sampling parameter is inversely proportional
to the outcome measure, while a positive sign indicates that the parameter is
directly proportional to the outcome [36]. In Figure 19 we observe that the
attack rate of A(H1) is negatively correlated to its own vaccine e cacy wA(H1),
but positively correlated to the other vaccine e cacies, wA(H3) and wB . This
means that a reduction in wA(H1) will increase the fraction of A(H1)-infected,
while a reduction in wB will decrease the fraction of A(H1)-infected – as seen
in Figure 15 first column (note that the PRCC value of wA(H3) corresponding
to the A(H1) attack rate is less than 0.5, suggesting a weak influence on this
attack rate). Similar results are shown for the other two influenza strains.
Figure 19: Attack rate of di↵erent influenza viruses (A(H1), A(H3), B) against di↵erent vac-
cine e cacies (wA(H1), wA(H3), wB) tested in PRCC of R package sensitivity. We simulate for
25 weeks with a step size 1/7 week (1 day) and 1000 random samples of (wA(H1), wA(H3), wB).
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3.6. Critical Vaccination Threshold
The equation for the critical vaccination threshold Vc, when considering the
vaccine e cacy w, is [37]:
Vc =
⇣
1  1
R0
⌘
· 1
w
, (18)
where R0 is the basic reproductive ratio. The formulation of this equation is
discussed in Appendix D. By substituting the parameter values from Table 6 into
(18) we can obtain the thresholds of di↵erent influenza subtypes which are listed
in Table 8. Noted here that all Vc calculated with 100% VE are higher than
the original maximum vaccinated population (⇠ 11.6%). This could explain
the result in Section 3.3 where the lack of vaccination coverage resulted in an
epidemic even when the vaccine was perfect.
(a) (wA(H1), wA(H3), wB) = (0.67, 0.25, 0.4), and Vc given by 2
nd column of Table 8.
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(b) (wA(H1), wA(H3), wB) = (1, 1, 1), and Vc given by 3
rdcolumn of Table 8.
Figure 20: The dynamics of SVIR model 2, for di↵erent critical vaccination threshold Vc.
Except the original result, it is assumed that V (0) = Vc and no further vaccination took place
within the period.
Subtype Vc with baseline/original w Vc with 100% w
A(H1) 0.45 0.30
A(H3) 0.72 0.18
B 0.55 0.22
Table 8: Critical vaccination thresholds of di↵erent influenza subtypes.
In the following, we assume for simplicity that V (0) = Vc and no further vac-
cinations take place during the investigated time period (i.e., r = 0 in equation
(1)). Figure 20 shows the results of model 2 (as given by equations (10)) with Vc
calculated using the baseline VE (Figure 20a) and the 100% VE (Figure 20b).
It is obvious that when the highest Vc is introduced, all subtypes infections die
out at the beginning. Nonetheless, we observe in Figure 20 that reduced vac-
cination will lead to a delayed peak of infection in the influenza subtype that
required the highest Vc as given by Table 8 (see the A(H3) infected panel of
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Figure 20a, and the A(H1) infected panel of Figure 20b). Although the e↵ect of
vaccination from one season on the next season is not discussed in this paper,
we will return to this aspect in the “Discussion and Conclusion” Section.
3.7. Changes in vaccination threshold with respect to the vaccine e cacy
Based on the results of numerical simulations in Figure 13, 15, 16 and 20,
we can conclude that both vaccination coverage and vaccine e cacy needed to
be higher to prevent the 2017 - 2018 influenza epidemics in Hong Kong (so as
to enable the existence of herd immunity to prevent the spread of infections).
Figure 20 suggested that a minimum of 72% initial population was required to
be vaccinated to prevent influenza this season. This figure also suggested that
only a minimum of 30% vaccinated population is needed if a perfect vaccine is
introduced. Since it is generally di cult to achieve such high percentages (100%
VE or 72% V(0)), we have to determine the combinations that are practically
achievable.
In the following, we assume for simplicity that V (0) = Vc and no further
vaccination takes place within the period (i.e., r = 0 in equation (1)). We also
assume that the VE for all subtypes are the same (w = wA(H1) = wA(H3) = wB),
and calculate (using equation (18)) the Vc of di↵erent influenza subtypes as we
vary the VE. For each vaccine e cacy w, since we obtain di↵erent Vc corre-
sponding to di↵erent R0 for three di↵erent virus subtypes (see equation (18)),
we select the highest Vc such that all infections will die out at the beginning.
The results are shown in Figure 21. We observe that all other curves except the
original one are more or less superimposed on top of each other, meaning that
each pair (w, Vc) will lead to relatively similar results.
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b)
a)
Figure 21: (a) Critical vaccination thresholds correspond to di↵erent vaccine e cacies. The
highest vaccination threshold among each subtype is chosen to be the selected Vc. In equation
(18), we assume that w = wA(H1) = wA(H3) = wB but R0 is di↵erent for A(H1), A(H3),
and B (see Table 7). (b) The dynamics of SVIR model 2, for di↵erent vaccine e cacies
w and chosen critical vaccine threshold Vc as given by (a). Except the original result (i.e.
w0 = (0.67, 0.25, 0.4); see Table 6), it is assumed that V (0) = Vc and no further vaccination
took place within the period. The VE for all subtypes are assumed to be the same, i.e.,
w = wA(H1) = wA(H3) = wB .
Obviously, the vaccination threshold Vc in Figure 21 is still high compared
to the current vaccination threshold in Hong Kong (see Section 2.2). For this
reason, in Figure 22 we decided to investigate the dynamics of model 2 when
Vc is reduced by half. In this case we observe that the peak of total infection is
almost a quarter of the original peak (i.e., 0.005 vs. 0.02). These results provide
an insight for research and government to decide the best vaccine strategy on
the basis of vaccination coverage, vaccine e cacy and the size of epidemics.
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b)
a)
Figure 22: (a) Half of the critical vaccination thresholds Vc. (b) The dynamics of SVIR model
2, for di↵erent vaccine e cacies w and half of the critical vaccination threshold Vc as given
by (a). Except the original result (i.e. w0 = (0.67, 0.25, 0.4); see Table 6), it is assumed that
V (0) = Vc and no further vaccination took place within the period. The VE for all subtypes
are assumed to be the same, i.e., w = wA(H1) = wA(H3) = wB .
4. Discussion and Conclusion
In this study, two mathematical models have been developed to investigate
the Hong Kong influenza epidemic during the 2017 - 2018 winter based on the
overall epidemic and influenza viruses’ subtypes. Least squares method and
bootstrap method have been used for fitting the data to the models, to estimate
parameter values. Also, simple mathematical analysis has been carried out to
identify the reproductive ratios for the infections in the two models, as well as
the steady states and their stability.
Numerical simulations presented in this study emphasised the importance
of the vaccination coverage and vaccine e cacy in preventing the spread of in-
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fection (Section 3.1 and 3.3). The results showed that a perfect vaccine cannot
prevent the spread because of the low vaccination coverage (Section 3.3). Also,
the results suggested that the increase in the vaccine e cacy for one virus sub-
type may lead to an increase in the infections caused by a di↵erent virus subtype
even if the total number of infections was decreasing (Section 3.4). Therefore,
we had to determine the critical vaccination coverage so that infection spread
could be prevented in the future. Results showed that 72% and 30% of initial
population needed to be vaccinated to eliminate the infection from the begin-
ning, for the cases of current (baseline) vaccine e cacy and perfect vaccine
e cacy, respectively (Section 3.6). Since the data suggested that ⇠ 11.6% of
the Hong Kong population was vaccinated during the winter 2017 - 2018 season,
we hypothesise that more vaccines would be needed to prevent an epidemic in
the future.
Because di↵erent influenza subtypes have di↵erent vaccine e cacies (and the
e cacies also vary every year [38]), the only way to stop the infection spread is to
select the highest critical vaccination threshold among all virus subtypes, once
the vaccine e cacies are predicted. By choosing this threshold as the required
vaccination coverage, it can ensure that all infections subtypes are eliminated
at the beginning of the season (Section 3.7). Moreover, the numerical results
have shown that the required coverage decreases with increasing e cacy.
We need to emphasise here the lack of data on cross-infection among the dif-
ferent influenza subtypes and on the e↵ect of vaccination from previous seasons,
which impeded us to investigate these aspects in the current study. However,
in the future we plan to investigate at a theoretical level the possible e↵ects
of viral cross-infections, or the possible impact of previous vaccinations (which
could lead to immune memory against similar viral antigens).
Finally, we note that one should investigate vaccine strategies in age-structured
populations, since it is more beneficial to determine the critical vaccine coverage
for each age group. However, as vaccine e cacy can vary between di↵erent ages
and since there is a lack of data on the age-dependent vaccine e cacy, this inves-
tigation was not carried out in this study. Future research plans (which would
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benefit from more detailed data collection) would consider the investigation of
the optimal vaccine coverage for each age group once the vaccine e cacies are
known, and the investigation of the cost-e↵ectiveness between a higher vaccine
coverage and a higher vaccine e cacy.
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Appendix
A. Vaccines’ Compositions
The Scientific Committee on Vaccine Preventable in Hong Kong reviewed
the scientific evidence of influenza vaccination and recommended the use of 2
vaccines comprising the following viruses [39]:
1. Trivalent (IIV3) inactivated influenza vaccine
• A/Michigan/45/2015 (H1N1)pdm09-like virus
• A/Hong Kong/4801/2014 (H3N2)-like virus
• B/Brisbane/60/2008-like virus
2. Quadrivalent (IIV4) inactivated influenza vaccine
• Above 3 viruses
• B/Phuket/3073/2013-like virus
Since we do not have detailed data on infections with di↵erent B strains,
throughout this study we focus only on the trivalent vaccine.
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B. Mathematical Analysis of Model 1
We consider the case when a single infected individual is introduced into
a fully susceptible population, i.e., I ⇡ 0, R = V = Ve = 0 ) S ⇡ 1, and
therefore
dI
dt
⇡  I
✓
 
 
  1
◆
.
We define the basic reproductive ratio as the threshold ratio that determines
the decay/growth of infections:
R0 =
 
 
. (19)
However, in many circumstances, not all individuals are susceptible to infec-
tions as some of them might have been vaccinated or might have had enough
immunity to prevent the infection. In order to improve the accuracy of the
approximation, one uses the e↵ective reproductive ratio R0x, which is defined
as the expected number of secondary infections caused by a single infection in-
troduced into a population made up of both susceptible and non-susceptible
individuals. We consider the case when a single infected individual is intro-
duced into a population formed of susceptible and vaccinated individuals. If we
assume that I ⇡ 0, R ⇡ 0, V = Ve = V0 with V0 < 1, it leads to S ⇡ 1   V0,
and therefore
dI
dt
⇡  I
✓
 (1  wV0)
 
  1
◆
.
We thus define
R0x =
 
 
(1  wV0). (20)
Then if R0x > 1 the infection will spread, and if R0x < 1 the infection will die
out. Using the parameter values from Table 3, we obtain
R0 =
2.7516
2.1272
⇡ 1.2935
R0x ⇡ 2.7516
2.1272
(1  0.45 · 0.0565) ⇡ 1.2607 > 1.
Since R0x > 1, it is clear that an influenza epidemic occurred during the study
period.
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The steady states of model 1 (described by equations (3)) are
(S, V, Ve, I, R) = (1  V ⇤  R⇤, V ⇤, A, 0, R⇤) ,
where 0  V ⇤, R⇤, V ⇤ + R⇤  1, V ⇤  A. The Jacobian matrix associated
with model 1 is given by
J(S, V, Ve, I, R) =
26666666664
  I 0 rA   S 0
0  kI   rA  kV 0
0 0   rA 0 0
 I kI 0  S + kV     0
0 0 0   0
37777777775
.
At the steady state,
J(1  V ⇤  R⇤, V ⇤, A, 0, R⇤) =
26666666664
0 0 rA   (1  V ⇤  R⇤) 0
0 0   rA  kV ⇤ 0
0 0   rA 0 0
0 0 0  (1  V ⇤  R⇤) + kV ⇤     0
0 0 0   0
37777777775
.
Since  r/A < 0 8A, r > 0, the only eigenvalue that a↵ects the stability of the
steady state is
  =  (1  V ⇤  R⇤) +  (1  w)V ⇤    
=  (1  wV ⇤  R⇤)   .
The steady state is stable if   < 0, i.e., if  (1  wV ⇤  R⇤) <  .
Next, we focus on the beginning of the influenza season and assume that
we are close to the disease-free steady state. Thus we consider R(0) = R⇤ and
V (0) = V ⇤, i.e.,
  =  
 
1  wV (0) R(0)    . (21)
It is noted that the above eigenvalue can be re-written as
  =  
⇣  1  wV (0) R(0) 
 
  1
⌘
=
8><>: (R0   1), R(0) = V (0) = 0 (22) (R0x   1), R(0) = 0 (23)
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Considering the disease-free and fully susceptible equilibrium where V (0) =
R(0) = 0, this equilibrium will be unstable if   >  , i.e., if R0 > 1. If we
instead consider the disease-free equilibrium where R(0) = 0 and V (0) = V0,
this equilibrium will be unstable if R0x > 1. Figure 23 shows the changes in
the stability of   for di↵erent vaccine e cacies w. We observe from this figure
that the disease-free and fully susceptible equilibrium (V (0) = R(0) = 0) is
always unstable for model 1. As the vaccine e cacy w increases, the vaccinated
population level V ⇤ = V (0) needed to ensure stable steady states decreases (see
the x-intercept of the lines   = 0 in Figure 23). We also observe that when
w = 0.1 and R(0) = 0, the disease-free equilibrium is unstable even when the
whole Hong Kong population is vaccinated (i.e., V (0) = 1)
Figure 23: The dynamics, in the (V (0), R(0)) space, of the eigenvalue   which determines
the stability of the steady states for model 1, as we vary the vaccine e cacies w. The lines
represent   = 0 for di↵erent w (see equation (21)). Parameters   = 2.7516,   = 2.1272 and
the baseline e cacy w0 = 0.45 are as in Table 3. The shaded area represents the values of
V (0) and R(0) where   > 0 (unstable steady states) in the case of w = w0.
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C. Mathematical Analysis of Model 2
The method used to calculate the reproductive ratios in model 2 is similar to
the one for model 1. If we re-arrange the di↵erential equations for the 3 infected
compartments to
dIi
dt
=  Ii
✓
 (S + (1  w)V )
 
  1
◆
, i = A(H1), A(H3), B,
then we can consider the case when 3 individuals, each infected by one of the
influenza subtype, are introduced into a fully susceptible population (i.e., Ii ⇡
0 8i, R = V = Ve = 0, which allows us to approximate S ⇡ 1). Then
dIi
dt
⇡  iIi
✓
 i
 i
  1
◆
,
and we can define the reproductive ratios to be the following thresholds:
R0i =
 i
 i
, i = A(H1), A(H3), B. (24)
Next we consider the case when three individuals, each infected by one of the
influenza subtypes, are introduced into a population formed of both susceptible
and vaccinated individuals (i.e., Ii ⇡ 0 8i, R ⇡ 0, V = Ve = V0, V0 < 1, which
allows us to approximate the susceptible population as S ⇡ 1  V0). Then
dIi
dt
⇡  iIi
✓
 i(1  wiV0)
 i
  1
◆
.
Define
R0xi =
 i
 i
(1  wiV0), i = A(H1), A(H3), B. (25)
The disease-free steady states for model 2 are
(S, V, Ve, IA(H1), IA(H3), IB , R) = (1  V ⇤  R⇤, V ⇤, A, 0, 0, 0, R⇤),
where 0  V ⇤, R⇤, V ⇤ + R⇤  1, V ⇤  A. The Jacobian matrix associated
with model 2 is given by
J(S, V, Ve, IA(H1), IA(H3), IB , R) =
43
=26666666666666664
 P3i=1  iIi 0 rA   1S   2S   3S 0
0  P3i=1 kiIi   rA  k1V  k2V  k3V 0
0 0   rA 0 0 0 0
 1I1 k1I1 0  1S + k1V    1 0 0 0
 2I2 k2I2 0 0  2S + k2V    2 0 0
 3I3 k3I3 0 0 0  3S + k3V    3 0
0 0 0  1  2  3 0
37777777777777775
At the disease-free steady state, the Jacobian matrix reads
J(1  V ⇤  R⇤, V ⇤, A, 0, 0, 0, R⇤) =
=
26666666666666664
0 0 rA   1(1  V ⇤  R⇤)   2(1  V ⇤  R⇤)   3((1  V ⇤  R⇤) 0
0 0   rA  k1V ⇤  k2V ⇤  k3V ⇤ 0
0 0   rA 0 0 0 0
0 0 0  1(1  w1V ⇤  R⇤)   1 0 0 0
0 0 0 0  2(1  w2V ⇤  R⇤)   2 0 0
0 0 0 0 0  3(1  w3V ⇤  R⇤)   3 0
0 0 0  1  2  3 0
37777777777777775
Since  r/A < 0 8A, r > 0, the only eigenvalues that are able to a↵ect the
stability of the steady state are
 j =  j(1  wjV ⇤  R⇤)   j , j = A(H1), A(H3), B. (26)
If the inequality
 j(1  wjV ⇤  R⇤)   j > 0
is satisfied for any virus subtype j, then the steady states are unstable.
D. Critical Vaccination Threshold
Herd immunity implies that if a su cient number of individuals in a pop-
ulation have obtained immunity, the infection will die out without causing an
epidemic. The standard herd immunity threshold for random vaccination is
Vc = 1  1
R0
,
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where Vc stands for the critical vaccination threshold while assuming 100% VE
[40]. However, it is generally di cult to obtain a perfect influenza vaccine, and
thus a new equation that included the vaccine e cacy w was introduced by
Plans and Rubio [37]:
Vc =
⇣
1  1
R0
⌘
· 1
w
. (27)
If we consider the equations (19) and (20) for R0 and R0x, we can rewrite
equation (27) for Vc as follows:
Vc =
⇣
1  1
R0
⌘
· 1
w
, R0(1  wVc) = 1 , R0x = 1.
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